Abstract
Background
Transcatheter aortic valve implantation (TAVI) is emerging as the standard of care for patients with severe aortic stenosis. Recent results have been favourable even for patients with low periprocedural risk.
Methods
We analysed the number of procedures, complications, and in-hospital mortality rates of all patients undergoing isolated aortic valve replacement in 2017 in Germany, focussing especially on transvascular (TV) TAVI. Patients were stratified according the German Aortic Valve Score (AKL) into the risk classes low, intermediate, high and very high (≥ 10%).
Results
A total of 17,956 TV-TAVI and 9011 isolated surgical aortic valve replacements (iSAVR) were performed in Germany in 2017. Although the total rate of intraprocedural complications after TV-TAVI was the same as in 2016 (both 7.4%), fewer patients experienced an arterial vascular complication in 2017 (2017: 6.0%; 2016: 7.1%; p < 0.001). Likewise, the rate of new pacemaker implantation decreased (2017: 9.6%; 2016:11.4%; p < 0.001). In-hospital mortality after TV-TAVI and iSAVR was equal (2.7%) in 2017, despite the much higher risk profile of TV-TAVI patients. Using the AKL score as reference, TV-TAVI showed a more favourable observed-to-expected mortality (O/E) ratio (0.89) than iSAVR (1.14)- even more pronounced in patients at low risk (0.81 vs. 1.14).
Conclusions
The rates of major complications like bleeding and permanent pacemaker implantation after TV-TAVI keep declining. In 2017 patients undergoing TV-TAVI had a low in-hospital mortality rate with an O/E ratio < 1, indicating that the results were again better than those of all TAVI and SAVR of the previous year.
Graphic abstract
Overall in-hospital mortality after transvascular TAVI and isolated aortic valve repair 2017 in Germany stratified to risk groups by the German Aortic Valve Score (German AV Score/AKL Score): low risk group (AKL 0– < 3%), intermediate risk group (AKL 3– < 6%), high risk group (AKL 6– < 10%) and very high risk group (AKL ≥ 10%)
Similar content being viewed by others
References
Baumgartner H, Falk V, Bax JJ et al (2017) 2017 ESC/EACTS guidelines for the management of valvular heart disease The task force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European. Eur Heart J 38:2739–2791. https://doi.org/10.1093/eurheartj/ehx391
Leon M, Smith C, Mack M, Miller D, Moses J, Svensson L, Tuzcu M, Webb J, Fontana G, Makkar R, Brown D, Block P, Guyton R, Pichard A, Bavaria J, Herrmann H, Douglas P, Peterson J, Akin J, Anderson W, Wand D, Pcocock S, for the PTI (2010) Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363:1597–1607
Smith C, Leon M, Mack M, Miller D, Moses J, Svnesson L, Tuzcu E, Webb J, Fontana G, Makkar R, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani V, Corso P, Pichard A, Bavaria J, Herrmann H, Akin J, Anderson W, Wang D, PS for the PTI (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364:2187–2198
Mack MJ, Leon MB, Smith CR et al (2015) 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 385:2477–2484. https://doi.org/10.1016/S0140-6736(15)60308-7
Thourani VH, Kodali S, Makkar RR et al (2016) Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet 387:2218–2225. https://doi.org/10.1016/S0140-6736(16)30073-3
Trenkwalder T, Pellegrini C, Holzamer A et al (2018) Prophylactic ECMO during TAVI in patients with depressed left ventricular ejection fraction. Clin Res Cardiol. https://doi.org/10.1007/s00392-018-1364-6
Reardon MJ, Van Mieghem NM, Popma JJ et al (2017) Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med 376:1321–1331. https://doi.org/10.1056/NEJMoa1700456
Leon MB, Smith CR, Mack MJ et al (2016) Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 374:1609–1620. https://doi.org/10.1056/NEJMoa1514616
Mack M, Leon M, Thourani V et al (2019) Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. https://doi.org/10.1056/nejmoa1814052
Popma J, Deeb G, Yakubov S et al (2019) Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. https://doi.org/10.1056/nejmoa1816885(epub ahead:1–10)
Doenst T, Bargenda S, Kirov H et al (2019) Cardiac surgery 2018 reviewed. Clin Res Cardiol. https://doi.org/10.1007/s00392-019-01470-6
Kim WK, Hamm CW (2018) Transcatheter aortic valve implantation in Germany. Clin Res Cardiol. https://doi.org/10.1007/s00392-018-1297-0
Frerker C, Bestehorn K, Schlüter M et al (2017) In-hospital mortality in propensity-score matched low-risk patients undergoing routine isolated surgical or transfemoral transcatheter aortic valve replacement in 2014 in Germany. Clin Res Cardiol 106:610–617. https://doi.org/10.1007/s00392-017-1097-y
Hamm CW, Möllmann H, Holzhey D et al (2014) The German Aortic Valve Registry (GARY): in-hospital outcome. Eur Heart J 35:1588–1598. https://doi.org/10.1093/eurheartj/eht381
Bekeredjian R, Szabo G, Balaban Ü et al (2018) Patients at low surgical risk as defined by the Society of Thoracic Surgeons Score undergoing isolated interventional or surgical aortic valve implantation: in-hospital data and 1-year results from the German Aortic Valve Registry (GARY). Eur Heart J. https://doi.org/10.1093/eurheartj/ehy699
Walther T, Hamm CW, Schuler G et al (2015) Peri-operative results and complications in 15,964 transcatheter aortic valve implantations from the German Aortic valve Registry (GARY). J Am Coll Cardiol 65:2173–2180. https://doi.org/10.1016/j.jacc.2015.03.034
Mohr FW, Holzhey D, Möllmann H et al (2014) The German Aortic Valve Registry: 1-year results from 13,680 patients with aortic valve disease. Eur J Cardio-Thorac Surg 46:808–816. https://doi.org/10.1093/ejcts/ezu290
Möllmann H, Bestehorn K, Bestehorn M et al (2016) In-hospital outcome of transcatheter vs. surgical aortic valve replacement in patients with aortic valve stenosis—complete dataset of patients treated in 2013 in Germany. Clin Res Cardiol 105:553–559
Gaede L, Blumenstein J, Kim W-K et al (2017) Trends in aortic valve replacement in Germany in 2015: transcatheter versus isolated surgical aortic valve repair. Clin Res Cardiol 106:411–419. https://doi.org/10.1007/s00392-016-1070-1
Gaede L, Kim W-K, Blumenstein J et al (2017) Temporal trends in transcatheter and surgical aortic valve replacement. Herz 42:316–324. https://doi.org/10.1007/s00059-016-4461-1
Gaede L, Blumenstein J, Liebetrau C et al (2018) Outcome after transvascular transcatheter aortic valve implantation in 2016. Eur Heart J 39:667. https://doi.org/10.1093/eurheartj/ehx688
Werner N, Zahn R, Beckmann A et al (2018) Patients at intermediate surgical risk undergoing isolated interventional or surgical aortic valve implantation for severe symptomatic aortic valve stenosis. One-Year results from the German Aortic Valve Registry. Circulation 138:2611–2623. https://doi.org/10.1161/circulationaha.117.033048
Waksman R, Rogers T, Torguson R, Gordon P, Ehsan A, Wilson SR, Goncalves J, Levitt R, Hahn C, Parikh P, Bilfinger T, Butzel D (2018) Transcatheter aortic valve replacement in low-risk patients with symptomatic severe aortic stenosis. JACC 72:2095–2104. https://doi.org/10.4244/eij-d-17-00584
Eggebrecht H, Mehta RH (2016) Transcatheter aortic valve implantation (TAVI) in Germany 2008–2014: on its way to standard therapy for aortic valve stenosis in the elderly? EuroIntervention 11:1029–1033
Kappetein AP, Head SJ, Généreux P et al (2012) Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol 60:1438–1454. https://doi.org/10.1016/j.jacc.2012.09.001
Parolari A, Pesce LL, Trezzi M et al (2010) EuroSCORE performance in valve surgery: a meta-analysis. Ann Thorac Surg 89:787–793.e2. https://doi.org/10.1016/j.athoracsur.2009.11.032
Kötting J, Schiller W, Beckmann A et al (2013) German aortic valve score: a new scoring system for prediction of mortality related to aortic valve procedures in adults. Eur J Cardio-thorac Surg 43:971–977. https://doi.org/10.1093/ejcts/ezt114
Schymik G, Herzberger V, Bergmann J et al (2018) Evolution of transcatheter aortic valve implantation over 7 years: results of a prospective single-centre registry of 2000 patients in a large municipal hospital (TAVIK Registry). BMJ Open 8:e022574. https://doi.org/10.1136/bmjopen-2018-022574
Barbanti M, Capranzano P, Ohno Y et al (2015) Comparison of suture-based vascular closure devices in transfemoral transcatheter aortic valve implantation. EuroIntervention 11:690–697. 10.4244/eijv11i6a137\reijv11i6a137
Urena M, Rodés-Cabau J (2015) Permanent pacemaker implantation following transcatheter aortic valve replacement. JACC Cardiovasc Interv 8:70–73. https://doi.org/10.1016/j.jcin.2014.09.010
Fujita B, Kütting M, Seiffert M et al (2016) Calcium distribution patterns of the aortic valve as a risk factor for the need of permanent pacemaker implantation after transcatheter aortic valve implantation. Eur Heart J Cardiovasc Imaging 17:1385–1393. https://doi.org/10.1093/ehjci/jev343
Gaede L, Kim W-K, Liebetrau C et al (2018) Pacemaker implantation after TAVI: predictors of AV block persistence. Clin Res Cardiol. https://doi.org/10.1007/s00392-017-1158-2
Gonska B, Seeger J, Keßler M et al (2017) Predictors for permanent pacemaker implantation in patients undergoing transfemoral aortic valve implantation with the Edwards Sapien 3 valve. Clin Res Cardiol. https://doi.org/10.1007/s00392-017-1093-2(epub ahead of print)
Erkapic D, De Rosa S, Kelava A et al (2012) Risk for permanent pacemaker after transcatheter aortic valve implantation: a comprehensive analysis of the literature. J Cardiovasc Electrophysiol 23:391–397. https://doi.org/10.1111/j.1540-8167.2011.02211.x
Mauri V, Deuschl F, Frohn T et al (2018) Predictors of paravalvular regurgitation and permanent pacemaker implantation after TAVR with a next-generation self-expanding device. Clin Res Cardiol 107:688–697. https://doi.org/10.1007/s00392-018-1235-1
Möllmann H, Hamm CW, Gaede L (2018) European Heart Journal, discussion forum. Eur Heart J. https://doi.org/10.1093/eurheartj/ehy741
Gummert J, Funkat A, Osswald B et al (2009) EuroScore overestimates the risk of cardiac surgery: results from the national registry of the German Society of Thoracic and Cardiovascular Surgery. Clin Res Cardiol 98:363–369. https://doi.org/10.1017/CBO9781107415324.004
Nilsson J, Algotsson L, Höglund P et al (2006) Comparison of 19 pre-operative risk stratification models in open-heart surgery. Eur Heart J 27:867–874. https://doi.org/10.1017/CBO9781107415324.004
Durand E, Borz B, Godin M et al (2013) Performance analysis of EuroSCORE II compared to the original logistic EuroSCORE and STS scores for predicting 30-day mortality after transcatheter aortic valve replacement. Am J Cardiol 111:891–897. https://doi.org/10.1016/j.amjcard.2012.11.056
Acknowledgements
We thank Elizabeth Martinson, PhD, of the KHFI Editorial Office for her editorial assistance. We thank Emilie Hofstetter for her assistance in analysing the data.
Funding
There was no funding for this work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Helge Möllmann received speaker honoraria and/or travel grants from Edwards Lifesciences, Abbott, Biotronik, Boston Scientific, St. Jude Medical, Symetis SA. Luise Gaede and Johannes Blumenstein report personal fees from Edwards Lifesciences, Abbott and Boston Scientific. Christian Hamm is advisor to Medtronic. Christoph Liebetrau reports personal fees from Abbott. Holger Nef reports personal fees from Boston Scientific. Won-Keun Kim reports personal fees from Boston Scientific, Abbott, Edwards Lifesciences, Medtronic. All other authors have no conflict of interest to declare.
Rights and permissions
About this article
Cite this article
Gaede, L., Blumenstein, J., Liebetrau, C. et al. Transvascular transcatheter aortic valve implantation in 2017. Clin Res Cardiol 109, 303–314 (2020). https://doi.org/10.1007/s00392-019-01509-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-019-01509-8